Rhumbline Advisers G1 Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $103 Billion
  • Q1 2024

A detailed history of Rhumbline Advisers transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 967 shares of GTHX stock, worth $2,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
967
Previous 967 -0.0%
Holding current value
$2,485
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$2.46 - $3.14 $2,378 - $3,036
967 New
967 $2,000
Q2 2022

Aug 11, 2022
SELL
$4.04 - $8.51 $190,320 - $400,897
-47,109 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$7.6 - $11.02 $121 - $176
-16 Reduced 0.03%
47,109 $358,000
Q4 2021

Feb 10, 2022
BUY
$10.16 - $16.17 $660 - $1,051
65 Added 0.14%
47,125 $481,000
Q3 2021

Nov 12, 2021
BUY
$13.16 - $22.47 $14,186 - $24,222
1,078 Added 2.34%
47,060 $632,000
Q2 2021

Aug 05, 2021
SELL
$19.57 - $26.32 $68,416 - $92,014
-3,496 Reduced 7.07%
45,982 $1.01 Million
Q1 2021

May 06, 2021
SELL
$17.58 - $32.59 $76,596 - $141,994
-4,357 Reduced 8.09%
49,478 $1.19 Million
Q4 2020

Feb 10, 2021
BUY
$10.99 - $20.4 $62,840 - $116,647
5,718 Added 11.88%
53,835 $968,000
Q3 2020

Nov 12, 2020
SELL
$11.55 - $23.75 $76,715 - $157,747
-6,642 Reduced 12.13%
48,117 $556,000
Q2 2020

Aug 13, 2020
BUY
$9.57 - $24.37 $67,401 - $171,637
7,043 Added 14.76%
54,759 $1.33 Million
Q1 2020

May 06, 2020
BUY
$9.07 - $26.32 $19,881 - $57,693
2,192 Added 4.82%
47,716 $526,000
Q4 2019

Feb 05, 2020
SELL
$20.54 - $31.0 $6,470 - $9,765
-315 Reduced 0.69%
45,524 $1.2 Million
Q3 2019

Oct 23, 2019
BUY
$22.78 - $40.58 $40,616 - $72,354
1,783 Added 4.05%
45,839 $1.04 Million
Q2 2019

Aug 14, 2019
BUY
$16.03 - $31.1 $228,283 - $442,895
14,241 Added 47.76%
44,056 $1.35 Million
Q1 2019

May 01, 2019
BUY
$14.4 - $21.45 $22,593 - $33,655
1,569 Added 5.55%
29,815 $495,000
Q4 2018

Jan 31, 2019
BUY
$16.51 - $51.33 $161,335 - $501,596
9,772 Added 52.9%
28,246 $541,000
Q3 2018

Nov 07, 2018
SELL
$43.15 - $67.97 $44,358 - $69,873
-1,028 Reduced 5.27%
18,474 $966,000
Q2 2018

Aug 06, 2018
BUY
$35.06 - $51.17 $272,486 - $397,693
7,772 Added 66.26%
19,502 $848,000
Q1 2018

May 02, 2018
BUY
$19.05 - $41.76 $223,456 - $489,844
11,730 New
11,730 $435,000

Others Institutions Holding GTHX

# of Institutions
95
Shares Held
14.7M
Call Options Held
631K
Put Options Held
347K
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $110M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email